Search Results

• • 22 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Opportunities and challenges in the era of molecularly targeted agents and radiation therapy

  Authors:Steven H. Lin, Thomas J. George, Edgar Ben-Josef, Jeffrey Bradley, Kevin S. Choe, Martin J. Edelman, et al.From:Journal of the National Cancer Institute (Vol. 105, Issue 10) Peer-Reviewed

  May 15, 2013160 words Author abstract

   Abstract Only

• Current status and future potential of advanced technologies in radiation oncology: part 1. Challenges and resources

  Authors:Bhadrasain Vikram, C. Norman Coleman, and James A. DeyeFrom:Oncology (Vol. 23, Issue 3) Peer-Reviewed

  Mar. 20093,301 words Article 1770LIn 2006, the Radiation Research Program of the Division of Cancer Treatment and Diagnosis of the National Cancer Institute hosted a workshop intended to address current issues related to advanced radiation therapy...

• Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy

  Authors:Minoru Uematsu, Nancy J. Tarbell, Barbara Silver, C. Norman Coleman, David S. Rosenthal, Lawrence N. Shulman, et al.From:Cancer (Vol. 72, Issue 1) Peer-Reviewed

  July 1, 1993282 words Article

   Abstract Only

• Combining targeted agents with modern radiotherapy in soft tissue sarcomas

  Authors:Philip Wong, Peter Houghton, David G. Kirsch, Steven E. Finkelstein, Arta M. Monjazeb, Meng Xu-Welliver, et al.From:Journal of the National Cancer Institute (Vol. 106, Issue 11) Peer-Reviewed

  Nov. 12, 2014231 words Author abstract, Rep...

   Abstract Only

• Prognostic factors for patients with Hodgkin disease in first relapse

  Authors:Elizabeth A. Healey, Nancy J. Tarbell, Leslie A. Kalish, Barbara Silver, David S. Rosenthal, Karen Marcus, et al.From:Cancer (Vol. 71, Issue 8) Peer-Reviewed

  Apr. 15, 1993253 words Article

   Abstract Only

• Prostate cancer: technology versus biology

  Authors:C. Norman Coleman and Irving D. KaplanFrom:Cancer (Vol. 72, Issue 2) Peer-Reviewed

  July 15, 1993 Editorial

   Citation Only

• Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas

  Authors:Patrick Y. Wen, Eben Alexander, III, Peter M. Black, Howard A. Fine, Nancy Riese, Jonathan M. Levin, et al.From:Cancer (Vol. 73, Issue 12) Peer-Reviewed

  June 15, 1994264 words Article

   Abstract Only

• NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers

  Authors:Yaacov Richard Lawrence, Bhadrasain Vikram, James J. Dignam, Arnab Chakravarti, Mitchell Machtay, Boris Freidlin, et al.From:Journal of the National Cancer Institute (Vol. 105, Issue 1) Peer-Reviewed

  Jan. 2, 2013239 words Brief article

   Abstract Only

• The use of probenecid as a chemoprotector against cisplatin nephrotoxicity

  Authors:Charlotte Jacobs, Sonja Kaubisch, Joanne Halsey, Bert L. Lum, Michael Gosland, C. Norman Coleman, et al.From:Cancer (Vol. 67, Issue 6(1-2)) Peer-Reviewed

  Mar. 15, 1991303 words Article

   Abstract Only

• Radiation research society Failla Award lecture, 2016: The radiation stress response: Of the people, by the people and for the people

  Author:C. Norman ColemanFrom:Radiation Research (Vol. 187, Issue 2) Peer-Reviewed

  Feb. 20179,643 words Report 1540L

   Citation Only

• Modulation of radiation injury

  Authors:C. Norman Coleman, Helen B. Stone, John E. Moulder, and Terry C. PellmarFrom:Science (Vol. 304, Issue 5671) Peer-Reviewed

  Apr. 30, 20041,041 words Article 1360LIonizing radiation is present all around us; exposure to background radiation from cosmic rays and naturally occurring isotopes is unavoidable. We are exposed during diagnostic and therapeutic medical procedures and in...

• Current status and future potential of advanced technologies in radiation oncology: part 2. State of the science by anatomic site

  Authors:Bhadrasain Vikram, C. Norman Coleman, and James A. DeyeFrom:Oncology (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 15, 20093,834 words Report 1480LIn December 2006, the Radiation Research Program of the Division of Cancer Treatment and Diagnosis of the National Cancer Institute hosted a workshop intended to address current issues related to advanced radiation...

• Patterns of presentation of Hodgkin disease: implications for etiology and pathogenesis

  Authors:Peter M. Mauch, Leslie A. Kalish, Marshall Kadin, C. Norman Coleman, Robert Osteen, and Samuel HellmanFrom:Cancer (Vol. 71, Issue 6) Peer-Reviewed

  Mar. 15, 1993365 words Article

   Abstract Only

• Radiation-induced fibrosis: mechanisms and opportunities to mitigate. Report of an NCI Workshop, September 19, 2016

  Authors:Deborah E. Citrin, Pataje G.S. Prasanna, Amanda J. Walker, Michael L. Freeman, Iris Eke, Mary Helen Barcellos-Hoff, et al.From:Radiation Research (Vol. 188, Issue 1) Peer-Reviewed

  July 201716,776 words Report 1520L

   Citation Only

• Medical Response to a Radiologic/Nuclear Event: Integrated Plan From the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services

  Authors:C. Norman Coleman, Chad Hrdina, Judith L. Bader, Ann Norwood, Robert Hayhurst, Joseph Forsha, et al.From:Annals of Emergency Medicine (Vol. 53, Issue 2) Peer-Reviewed

  Feb. 2009465 words Report

   Abstract Only

• Medical Response to a Radiologic/Nuclear Event: Integrated Plan From the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services

  Authors:C. Norman Coleman, Chad Hrdina, Judith L. Bader, Ann Norwood, Robert Hayhurst, Joseph Forsha, et al.From:Annals of Emergency Medicine (Vol. 53, Issue 2) Peer-Reviewed

  Feb. 2009465 words Report

   Abstract Only

• A blueprint for linking academic oncology and the community

  Authors:Rita Linggood, Frank Govern, and C. Norman ColemanFrom:Journal of Health Politics, Policy and Law (Vol. 23, Issue 5) Peer-Reviewed

  Dec. 1998146 words Article

   Citation Only

• Radioimmunotherapy with alpha-particle-emitting immunoconjugates

  Authors:Roger M. Macklis, Berma M. Kinsey, Amin I. Kassis, James L.M. Ferrara, Robert W. Atcher, John J. Hines, et al.From:Science (Vol. 240, Issue 4855) Peer-Reviewed

  May 20, 19881,770 words Article Radioimmunotheraphy with Alpha-Particle-Emitting Immunoconjugates RADIONUCLIDES THAT EMIT [ALPHA]-PARTicles have a number of physical characteristics that make them attractive candidates for radioimmunotheraphy (1)....

• Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma

  Authors:Sylvia A. Holden, Beverly A. Teicher, Gulshan Ara, Terence S. Herman, and C. Norman ColemanFrom:Journal of the National Cancer Institute (Vol. 84, Issue 3) Peer-Reviewed

  Feb. 5, 1992 Article

   Citation Only

• Radiotherapy for hepatocellular carcinoma: new indications and directions for future study

  Authors:Nitin Ohri, Laura A. Dawson, Sunil Krishnan, Jinsil Seong, Jason C. Cheng, Shiv K. Sarin, et al.From:Journal of the National Cancer Institute (Vol. 108, Issue 9) Peer-Reviewed

  Sept. 14, 2016129 words Author abstract, Rep...

   Abstract Only